Stay updated on Safety of Iptacopan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.

Latest updates to the Safety of Iptacopan in IgA Nephropathy Clinical Trial page
- Check6 days agoChange DetectedThe latest version shows Revision: v3.3.2 replacing v3.3.1 in the Record History; this is a minor metadata update with no visible changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoChange DetectedA new revision entry v3.3.1 has been added to the record history. The v3.2.0 revision entry has been removed.SummaryDifference0.1%

- Check21 days agoChange DetectedRemoved a site-wide funding/operating status banner. The change does not alter the study data or the information presented in the record history.SummaryDifference0.6%

- Check35 days agoChange DetectedA new entry was added to the Study Record Versions list. The rest of the page content remains unchanged.SummaryDifference0.1%

- Check64 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference11%

- Check71 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to Safety of Iptacopan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.